Baynes Roy D.
Natera, Inc. · Director
Baynes Roy D. serves as a Director at Natera, Inc., where he is involved in overseeing the company's strategic direction in the healthcare sector. His recent disclosures reflect a pattern of sale activity, with a total of six reported transactions between February 2025 and June 2026. Notably, the largest disclosed move was a sale of $1.1 million in Travere Therapeutics, Inc. on April 16, 2026, indicating a significant engagement with the healthcare investment landscape.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $431k9.8k shares | SellMay 1, 2026 | $44.22 | $55.74 | |
| $1M26k shares | SellApr 14, 2026 | $41.07 | $55.74 | |
| $284k6.8k shares | SellApr 14, 2026 | $42.12 | $55.74 | |
| $330k10k shares | SellApr 6, 2026 | $33.00 | $55.74 | |
| $220k10k shares | SellFeb 6, 2025 | $22.00 | $55.74 |